Learn about the role of HPV in cervical cancer
 
What's New

16. December 2014

Roche launches PCR molecular diagnostic system for point of care environment

The cobas® Liat System is the only FDA cleared molecular diagnostic platform to offer real- time PCR results in 20 minutes or less.

>more

08. December 2014

Roche launches next-generation viral load testing assays for new molecular diagnostic platforms in markets accepting the CE mark

Roche announced the commercial availability of the cobas® HIV-1 and cobas HCV assays for use on the cobas 6800/8800 Systems.

>more

 

13. November 2014

Roche Receives FDA Clearance for Strep A Test on cobas Liat System

The cobas Strep A test is the first molecular point of care test to provide a result in 15 minutes for this common infection.

>more

16. December 2014

Roche launches PCR molecular diagnostic system for point of care environment

The cobas® Liat System is the only FDA cleared molecular diagnostic platform to offer real- time PCR results in 20 minutes or less.

>more

 Diagnostic and Blood Screening Tests

 

Roche Molecular Diagnostics (RMD) offers a uniquely broad range of diagnostic and blood screening assays based on the company's Nobel prize-winning PCR technologies.

 

RMD's tests and automated platforms are focused in the areas of virology, blood screening, HPV, genomics and oncology, microbiology and sexually transmitted infections. > more

 Contact

Contact your local sales representative for detailed information, questions and ordering.

 

 

 Browse Our Products

 Related Links